Single centre, prospective, observational trial to evaluate effectiveness of omalizumab treatment in asthma-COPD overlap syndrome.
Phase of Trial: Phase IV
Latest Information Update: 16 Feb 2017
At a glance
- Drugs Omalizumab (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 16 Feb 2017 New trial record